VRTX Vertex Pharmaceuticals
- Official Name: VERTEX PHARMACEUTICALS INCORPORATED
- Headquarters: 50 Northern Avenue, BOSTON, MA, 02210 US
- CEO: Reshma Kewalramani
- Website: vrtx.com
- Key Investor: CAPITAL WORLD INVESTORS | 11.11%
- Dedicated Investor: BRIDGER MANAGEMENT, LLC | 9.89%
Match Results
| Date | League | Week | Opponent | Result | Score |
|---|---|---|---|---|---|
| 2025-07-15 | 1 | Lost by 4.762 | 1.661 - 6.423 | ||
| 2025-07-22 | 2 | Lost by 7.742 | 1.322 - 9.064 | ||
| 2025-07-29 | 3 | Lost by 2.706 | (0.929) - 1.777 | ||
| 2025-07-29 | 2R | Won by 0.079 | 1.319 - 1.240 | ||
| 2025-08-05 | 4 | Lost by 14.199 | (15.489) - (1.290) | ||
| 2025-08-07 | 1R | Won by 0.352 | 0.085 - (0.267) | ||
| 2025-08-12 | 5 | Won by 18.363 TOTW | 18.488 - 0.125 | ||
| 2025-08-12 | 3R | Won by 0.429 | 3.315 - 2.886 | ||
| 2025-08-19 | 6 | Lost by 0.736 | 2.315 - 3.051 | ||
| 2025-08-21 | 2R | Won by 2.266 | 0.980 - (1.286) | ||
| 2025-08-26 | 7 | Lost by 3.826 | (0.897) - 2.929 | ||
| 2025-08-26 | 4R | Lost by 0.702 | (0.484) - 0.218 | ||
| 2025-09-02 | 8 | Won by 3.542 TOTW | 3.429 - (0.113) | ||
| 2025-09-03 | 1R | Lost by 0.314 | (1.096) - (0.782) | ||
| 2025-09-04 | 3R | Lost by 2.088 | 0.078 - 2.166 | ||
| 2025-09-09 | 9 | Lost by 1.837 | (1.144) - 0.693 | ||
| 2025-09-16 | 10 | Won by 1.462 | (1.714) - (3.176) | ||
| 2025-09-23 | 11 | Lost by 8.059 | (2.919) - 5.140 | ||
| 2025-09-30 | 12 | Won by 3.632 | 3.003 - (0.629) | ||
| 2025-10-07 | 13 | Won by 2.135 | 4.689 - 2.554 | ||
| 2025-10-14 | 14 | Lost by 0.458 | 0.475 - 0.933 | ||
| 2025-10-21 | 15 | Won by 4.126 | 3.442 - (0.684) |
Latest News
Yahoo - 2026-09-04
Vertex vs. Regeneron: Which Biotech Giant Is the Better Buy Right Now?
They could both outperform the market over the medium term, but one appears to have a clear edge.
Benzinga - 2026-09-04
Here's How Much $100 Invested In Vertex Pharmaceuticals 20 Years Ago Would Be Worth Today
Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 20 years by 5.61% on an annualized basis producing an average annual re...
Yahoo - 2026-09-03
Vortex Energy Announces Plans for Ground Gravity Survey at the Robinsons River Salt Project
Next Phase of Geophysical Work Advances Priority Targets Following August Technical StudyVANCOUVER, British Columbia, Sept. 03, 2026 (GLOBE NEWSWIRE) ...
SeekingAlpha - 2026-09-03
The Market May Be Telling Us We're Entering A Capital Formation Cycle
My clustering stock screener is giving us a much more interesting macro signal than simply energy stocks are strong. The portfolio is not simply long ...
Yahoo - 2026-09-02
2 Reasons CRISPR Therapeutics Stock Could Soar in the Final 4 Months of 2026
We'll know a little more about the company's prospects by the end of the year.
Yahoo - 2026-09-02
Why Is Vertex (VRTX) Up 14.4% Since Last Earnings Report?
Vertex (VRTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Yahoo - 2026-09-02
How Is Vertex Pharmaceuticals' Stock Performance Compared to Other Biotech Stocks?
Vertex Pharmaceuticals has underperformed the Biotech industry over the past year, but analysts are moderately optimistic about the stock’s prospect...
Benzinga - 2026-09-02
Morgan Stanley Reinstates Overweight on Vertex Pharmaceuticals, Announces $665 Price Target
Morgan Stanley analyst Terence Flynn reinstates Vertex Pharmaceuticals (NASDAQ:VRTX) with a Overweight and announces $665 price target.
Yahoo - 2026-09-01
Vertex (VRTX) Stock Trades At A Premium On Earnings Yet Looks Fair On Broader Checks
Vertex Pharmaceuticals stock has delivered strong multi year gains, and current valuation checks suggest the shares now look closer to fairly priced t...
Yahoo - 2026-09-01
Goldman Sachs refreshes conviction lists on both sides of the Atlantic
Investing.com -- Goldman Sachs updated its U.S. and European conviction lists for September, adding several new names as it refreshed its highest-conv...
Yahoo - 2026-09-01
Vertex Pharmaceuticals (VRTX) Could Be 3% Undervalued If Its Pipeline Growth Holds
How Vertex Pharmaceuticals Stock Has Been Trading Recently Vertex Pharmaceuticals (VRTX) has drawn fresh investor attention as its share price reached...
Yahoo - 2026-09-01
Vertex Completes $10 Billion Crinetics Acquisition, Adding Rare Endocrine Growth Platform
The completed acquisition adds PALSONIFY and atumelnant to Vertex’s portfolio, with the two therapies carrying combined peak annual revenue potentia...
Yahoo - 2026-09-01
Vertex Completes Acquisition of Crinetics Pharmaceuticals and Announces Expansion of Executive Leadership Team
BOSTON, September 01, 2026--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the successful completion of the acquisition of Crineti...
Yahoo - 2026-09-01
OncoC4 Appoints Dr. Steve Chen, JD, PhD as General Counsel
OncoC4, Inc., a late clinical-stage biopharmaceutical company developing novel medicines for cancer and neurodegenerative diseases, today announced th...
Yahoo - 2026-08-31
1 S&P 500 Stock with Exciting Potential and 2 We Ignore
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face s...
Yahoo - 2026-08-31
Neurocrine's Crenessity Gains Ground in CAH: How Far Can Sales Go?
NBIX's Crenessity gains rapid traction in CAH, with sales soaring and low patient penetration leaving room for growth.
SeekingAlpha - 2026-08-31
Big Pharma's Comeback Is Here: Winners, Losers, And 4 ETFs
Big Pharma hits new 52-week highs on strong Q2 results; explore why some lag and which healthcare ETF offers best income risk/reward. Click for more a...
Show more
Benzinga - 2026-08-27
If You Invested $100 In Vertex Pharmaceuticals Stock 20 Years Ago, You Would Have This Much Today
Yahoo - 2026-08-26
Vertex to Participate in Upcoming September Investor Conferences
Yahoo - 2026-08-26
Vertex Pharmaceuticals Up 15% in a Month: How to Play the Stock
Yahoo - 2026-08-26
2 Large-Cap Stocks to Research Further and 1 We Question
Yahoo - 2026-08-24
Inflation Is Rising Again. History Says These 2 Stocks Are Among the Smartest Places to Hide
Benzinga - 2026-08-21
Uber, ServiceNow And A Health Care Stock On CNBC’s ‘Final Trades’
Yahoo - 2026-08-20
Vertex Pharmaceuticals' Rally Has a New Engine -- and Wall Street Thinks the Best Is Still Ahead
Yahoo - 2026-08-20
Are Wall Street Analysts Bullish on Vertex Stock?
Yahoo - 2026-08-19
HEALWELL AI's DARWEN(TM) AI Platform Nominated for 2026 International Prix Galien, the Global "Best of the Best" in Life Sciences Innovation
Yahoo - 2026-08-18
Vortex Energy Announces Final Ambient Noise Tomography Results for the Robinsons River Salt Project
Yahoo - 2026-08-18
3 Cash-Producing Stocks on Our Watchlist
Yahoo - 2026-08-14
Can AbCellera Biologics (ABCL)’s Vertex Pharmaceuticals Incorporated (VRTX) Deal Turn its TCE Platform Into a Breakthrough?
Yahoo - 2026-08-14
Vertex Pharmaceuticals Just Hit an All-Time High. Here's Why the Biotech Stock Could Soar Even More
Yahoo - 2026-08-14
Vertex Pharmaceuticals (VRTX) Could Be 8% Undervalued Following Raised 2026 Guidance
Yahoo - 2026-08-14
BofA biotech scorecard: Two buys and odd one out
Benzinga - 2026-08-14
$100 Invested In Vertex Pharmaceuticals 20 Years Ago Would Be Worth This Much Today
SeekingAlpha - 2026-08-14
Vertex Pharmaceuticals: I Was Wrong About Its Near-Term Prospects (Rating Upgrade)
Yahoo - 2026-08-13
Inside Latigo Biotherapeutics’ IPO: A Non-Opioid Pain Bet Goes Public
Yahoo - 2026-08-11
One Company’s Clinical Miss Is Another’s Moat: Vertex Rallies as Sionna’s CF Bet Collapses
Yahoo - 2026-08-11
4 Biotech Stocks With Major Second-Half Pipeline Catalysts This Year
Yahoo - 2026-08-10
Vertex (VRTX) Q2 2026 Earnings Call Transcript
ChartMill - 2026-08-10
Discover which S&P500 stocks are making waves on Monday.
Yahoo - 2026-08-10
SION Stock On Track For Worst Day Ever After 90% Drop — What’s Driving The Selloff?
ChartMill - 2026-08-10
Explore the top gainers and losers within the S&P500 index in today's session.
Yahoo - 2026-08-10
Why Sionna Therapeutics Stock Is Crashing 92% to a Record Low
Yahoo - 2026-08-10
Vertex Stock Jumps 5.9% as Rival Cystic Fibrosis Drug Fails
Yahoo - 2026-08-10
Vertex Pharmaceuticals (VRTX) Is Up 5.4% After Raising 2026 Revenue Guidance And Expanding Its Pipeline - Has The Bull Case Changed?
Yahoo - 2026-08-10
Why Vertex Pharma Popped, As A Key Rival Plummeted 90%
ChartMill - 2026-08-10
Get insights into the top movers in the S&P500 index of Monday's pre-market session.
Yahoo - 2026-08-10
Sionna cystic fibrosis drug fails key trial, removing threat to Vertex
SeekingAlpha - 2026-08-08
Tracking Tweedy Browne Portfolio - Q2 2026 Update
Yahoo - 2026-08-07
What Insmed Stock's Premium Is Actually Buying
Yahoo - 2026-08-06
IONQ Q2 Earnings Miss Estimates, Revenues Beat, Stock Rises
Yahoo - 2026-08-06
Vortex Energy Receives Final Technical Study Results for the Robinsons River Salt Project
Yahoo - 2026-08-06
AbCellera Biologics Inc (ABCL) (Q2 2026) Earnings Call Highlights: Strong Pipeline Progress and ...
Yahoo - 2026-08-05
AbCellera Biologics Q2 Earnings Call Highlights
Benzinga - 2026-08-05
Truist Securities Maintains Buy on Vertex Pharmaceuticals, Raises Price Target to $565
Yahoo - 2026-08-05
Entrada Therapeutics Reports Second Quarter 2026 Financial Results
SeekingAlpha - 2026-08-05
CRISPR: "Strong Buy" CASGEVY Sales Growth And In Vivo Expansion With CTX310
Benzinga - 2026-08-05
Barclays Maintains Overweight on Vertex Pharmaceuticals, Raises Price Target to $617
Yahoo - 2026-08-04
Vertex Pharmaceuticals' Solid Q2, Raised Outlook Underscore Core Business Strength, RBC Says
Yahoo - 2026-08-04
How Vertex Regained Its Footing On A Competitor's Bullish Report
Yahoo - 2026-08-04
VRTX's Q2 Earnings Lag Estimates, Revenues Top, 2026 Sales View Raised
Yahoo - 2026-08-04
CRISPR Therapeutics' Q2 Earnings & Revenues Surpass Estimates
Yahoo - 2026-08-04
VRTX Q2 Earnings Call Highlights Launch Momentum & Higher Outlook
Yahoo - 2026-08-04
Vertex Pharmaceuticals Incorporated Q2 2026 Earnings Call Summary
Benzinga - 2026-08-04
TD Cowen Maintains Buy on Vertex Pharmaceuticals, Raises Price Target to $550
Yahoo - 2026-08-04
Vertex’s biggest overhang: a rival 50 times smaller
Yahoo - 2026-08-04
Vertex (VRTX) Buys Crinetics To Push Beyond Cystic Fibrosis
Yahoo - 2026-08-04
Crinetics Pharmaceuticals (CRNX) Stock Looks Pricey As Buyout News Lands
Benzinga - 2026-08-04
Cantor Fitzgerald Maintains Overweight on Vertex Pharmaceuticals, Raises Price Target to $595
SeekingAlpha - 2026-08-04
Vertex Pharmaceuticals: A Transition Year Into A Multi-Franchise Growth Story
Yahoo - 2026-08-04
Vertex Pharmaceuticals Inc (VRTX) (Q2 2026) Earnings Call Highlights: Revenue Surges 12% to $3. ...
SeekingAlpha - 2026-08-03
Vertex Pharmaceuticals Incorporated (VRTX) Q2 2026 Earnings Call Transcript
Yahoo - 2026-08-03
Vertex Pharmaceuticals Q2 Earnings Call Highlights
SeekingAlpha - 2026-08-03
Vertex Pharmaceuticals Incorporated 2026 Q2 - Results - Earnings Call Presentation
Yahoo - 2026-08-03
Vertex (VRTX) Reports Q2 Earnings: What Key Metrics Have to Say
Yahoo - 2026-08-03
Vertex Pharmaceuticals (VRTX) Q2 Earnings Lag Estimates
Yahoo - 2026-08-03
Vertex Raises 2026 Guidance, But Shares Dip For One Key Reason
Yahoo - 2026-08-03
Vertex Pharmaceuticals (NASDAQ:VRTX) Beats Q2 CY2026 Sales Expectations, Full-Year Outlook Slightly Exceeds Expectations
Yahoo - 2026-08-03
Crinetics Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
Yahoo - 2026-08-03
Vertex Reports Second Quarter 2026 Financial Results
Benzinga - 2026-08-03
Vertex Pharmaceuticals Raises FY2026 Sales Guidance from $12.950B-$13.100B to $13.100B-$13.200B vs $13.065B Est
Benzinga - 2026-08-03
Vertex Pharmaceuticals Q2 Adj. EPS $4.73, Inline, Sales $3.334B Beat $3.232B Estimate
SeekingAlpha - 2026-08-03
Divided Tech, Divided Fed: Navigating AI Capex Scrutiny And Mixed Macro Signals
Yahoo - 2026-08-03
Falling Oil Boosts Wall Street Pre-Bell; Asia Mixed, Europe Up
Benzinga - 2026-08-02
Tyson Foods, Marriott And 3 Stocks To Watch Heading Into Monday
Benzinga - 2026-08-02
Nasdaq Jumps 1% as Amazon Shares Surge: Investor Sentiment Improves, But Greed Index Remains in 'Fear' Zone
Yahoo - 2026-07-31
Is The Recent Pullback In Alnylam Stock An Opportunity Or A Trap?
Yahoo - 2026-07-30
Vertex Just Paid $10 Billion for Crinetics. Here's Why Viking Therapeutics Could Be the Next Big Pharma Takeover Target
Yahoo - 2026-07-29
Vertex Pharmaceuticals (VRTX) Expands Its Pipeline Reach, Is The Stock Fully Valued?
Yahoo - 2026-07-29
Vertex Pharmaceuticals (VRTX) Stock Looks Like A Bargain At This Price
Yahoo - 2026-07-29
Vertex (VRTX) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
Yahoo - 2026-07-29
AbCellera, Vertex partner on next-gen T-cell engagers
Yahoo - 2026-07-29
AbCellera Announces Collaboration with Vertex to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Other Conditions
ChartMill - 2026-07-29
Vertex Pharmaceuticals (NASDAQ:VRTX): Strong Growth and Textbooks Technical Setup for Breakout
Yahoo - 2026-07-28
Analysts Estimate Gilead Sciences (GILD) to Report a Decline in Earnings: What to Look Out for
Yahoo - 2026-07-28
Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know
CNBC - 2026-07-28
Chris Young, Vertex CEO: A Fortt Knox Conversation
Yahoo - 2026-07-27
Vertex Gears Up to Report Q2 Earnings: What Can Investors Expect?
Yahoo - 2026-07-27
Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy?
Yahoo - 2026-07-24
Vortex Energy Corp. Announces Marketing Program
Yahoo - 2026-07-23
Is Arrowhead Pharmaceuticals Stock A Smart Buy After Its Transition To A Commercial Company?
Yahoo - 2026-07-23
3 Healthcare Stocks with Competitive Advantages
Yahoo - 2026-07-22
Vertex Pharmaceuticals (VRTX) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Yahoo - 2026-07-22
Vertex was sole bidder in high-premium Crinetics acquisition
Benzinga - 2026-07-21
These 7 Small Caps Are on Fire as the Second Half Begins: Here’s Why
Yahoo - 2026-07-21
A Diabetes Therapy Just Locked In Its Cell Supplier, and the Race to End Insulin Injections Is Heating Up
Yahoo - 2026-07-21
Biotech IPO Gains Crush AI Listings With Standout 55% Return
ChartMill - 2026-07-21
Vertex Pharmaceuticals (NASDAQ:VRTX): An Affordable Growth Stock Balancing Strong Fundamentals With Reasonable Valuation
Yahoo - 2026-07-20
Why Vertex Pharmaceuticals (VRTX) Dipped More Than Broader Market Today
Yahoo - 2026-07-20
How FDA’s Pediatric Expansion of Casgevy at Vertex Pharmaceuticals (VRTX) Has Changed Its Investment Story
Yahoo - 2026-07-16
1 Nasdaq 100 Stock to Keep an Eye On and 2 We Question
Yahoo - 2026-07-16
Collect 9.8% On VRTX Stock Now, And Still Keep 15% Of Upside
Yahoo - 2026-07-16
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It
Yahoo - 2026-07-16
Vortex Energy Provides Corporate Update on Robinsons River Salt Project Technical Study
SeekingAlpha - 2026-07-16
The Battle For Sickle Cell
Benzinga - 2026-07-15
$1000 Invested In Vertex Pharmaceuticals 5 Years Ago Would Be Worth This Much Today
Yahoo - 2026-07-15
IBB ETF Holds Fewer Bets Than You Think
Yahoo - 2026-07-14
Here's Why Vertex Was Willing to Pay a Premium of More Than 100% for Crinetics Pharmaceuticals
Yahoo - 2026-07-13
Vertex Pharmaceuticals (VRTX) Declines More Than Market: Some Information for Investors
Yahoo - 2026-07-13
Vortex Energy Corp. Announces Closing of LIFE Offering
Yahoo - 2026-07-13
Does Vertex's Acquisition of Crinetics Pharmaceuticals Make the Stock a No-Brainer Buy?
Benzinga - 2026-07-13
UBS Maintains Buy on Vertex Pharmaceuticals, Raises Price Target to $585
Benzinga - 2026-07-13
Truist Securities Maintains Buy on Vertex Pharmaceuticals, Raises Price Target to $560
Yahoo - 2026-07-11
Vertex Pharmaceuticals Bets $10 Billion on Crinetics to Build Endocrinology Powerhouse
Yahoo - 2026-07-10
Is This Biotech Stock a Buy Near Its 52-Week High?
Yahoo - 2026-07-10
Why This Pharmaceutical Stock Jumped Close to 100% This Week
Yahoo - 2026-07-10
If You Invested $1000 in Vertex Pharmaceuticals a Decade Ago, This is How Much It'd Be Worth Now
Yahoo - 2026-07-10
The Long Climb Back For Ionis Stock
Yahoo - 2026-07-10
Vertex Pharmaceuticals Just Made a $10 Billion Move. Is the Stock a Buy?
Yahoo - 2026-07-09
Vertex (VRTX) is One of the Best QQQ Stocks to Invest in
Yahoo - 2026-07-09
Why Crinetics Stock Soared 99% This Week
Yahoo - 2026-07-09
Jim Cramer Says Biotech is The Hottest Group in The Market Right Now
Yahoo - 2026-07-09
Cystic Fibrosis Market, Global & Regional Now Available; Profiles Vertex Pharmaceuticals, AbbVie, and Other Frontrunner Competitors in Orphan Drug Markets
Yahoo - 2026-07-09
1 Momentum Stock to Research Further and 2 Facing Headwinds
Benzinga - 2026-07-09
Nvidia, Vertex Pharmaceuticals And More On CNBC’s ‘Final Trades’
Yahoo - 2026-07-08
Why Did PENG, ANET, BCRX Shares Surge To 52-Week Highs?
Yahoo - 2026-07-08
Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says
Yahoo - 2026-07-08
Is Crinetics Pharmaceuticals, Inc. (CRNX) Stock a Buying Opportunity After a 44% Pullback?
CNBC - 2026-07-08
Software and cloud computing names have strong growth scenarios, says ETF Action's Mike Akins
Yahoo - 2026-07-08
Vertex (VRTX) Stock May Be 36% Undervalued Following Its $10b Deal
CNBC - 2026-07-08
Final Trades: Vertex, Nvidia, the DRAM and the VNQ
Yahoo - 2026-07-08
Vertex’s Crinetics Deal Balances Growth with Integration Risk
Benzinga - 2026-07-08
Hesai Says Co Selected By NVIDIA As Lidar Partner For NVIDIA DRIVE Hyperion 10
Yahoo - 2026-07-08
Collect 9.0% On VRTX Stock Now, And Still Keep 15% Of Upside
Yahoo - 2026-07-08
Viking Therapeutics (VKTX) Draws Takeover Focus After Vertex's $10 Billion Crinetics Deal
Yahoo - 2026-07-08
Vertex Is Paying a 102% Premium to Acquire Crinetics for $10 Billion. Here's Whether the Deal Is Worth It.
Yahoo - 2026-07-08
Strength Seen in CRINETICS PHARM (CRNX): Can Its 98.7% Jump Turn into More Strength?
Yahoo - 2026-07-08
VKTX Vs BCRX: Which Biotech Takeover Favorite Offers More Upside After Vertex’s $10B CRNX Deal?
Yahoo - 2026-07-07
Why Did CRNX, D, BCRX Stocks Surge To 52-Week Highs Today?
Yahoo - 2026-07-07
Why Crinetics Stock Doubled After Vertex’s $10 Billion Buyout
Yahoo - 2026-07-07
Vertex Pharmaceuticals (VRTX) Registers a Bigger Fall Than the Market: Important Facts to Note
Yahoo - 2026-07-07
Vertex to Announce Second Quarter 2026 Financial Results on August 3rd
Yahoo - 2026-07-07
Sector Update: Healthcare Stocks Gain Late Afternoon
Yahoo - 2026-07-07
Vertex Pays $10 Billion to Enter Rare Endocrine Disease
Yahoo - 2026-07-07
Top Midday Gainers
Yahoo - 2026-07-07
Jim Cramer Calls Biotech “The Hottest Group in the Market” as He Predicts “Deals Are Going to Be Flooding the Market”
Yahoo - 2026-07-07
Top Midday Stories: Amazon Seeking at Least $25 Billion From US Bond Sale; Fiserv Explores Sale of STAR Debit Network
Yahoo - 2026-07-07
CRISPR Therapeutics vs. Viking Therapeutics: Is a Gene-Editing or Weight Loss Focused Stock Is a Better Buy in 2026?
Yahoo - 2026-07-07
Crinetics Acquisition Creates A ‘Fifth Commercial Pillar’ For Vertex, Says Analyst – Why HC Wainwright Sees A 24% Upside Potential In VRTX Stock
Yahoo - 2026-07-07
VRTX to Strengthen Rare Disease Portfolio With $10B Crinetics Buyout
CNBC - 2026-07-07
Stocks making the biggest moves midday: SpaceX, GE Vernova, Crinetics Pharmaceuticals, Rivian & more
Yahoo - 2026-07-07
Vertex Sees Over $5 Billion Peak Sales Potential From Crinetics Assets
Yahoo - 2026-07-07
Vertex Pharmaceuticals buying Crinetics for $10 billion
Yahoo - 2026-07-07
Equities Mostly Down Pre-Bell Amid Broad Chip Stock Sell-Off
Yahoo - 2026-07-07
Intel, Corning, Super Micro, and More Stocks That Explain Today’s Market
Benzinga - 2026-07-07
RBC Capital Maintains Outperform on Vertex Pharmaceuticals, Raises Price Target to $570
Yahoo - 2026-07-07
Tech Weakness Resumes After Samsung Misses Lofty AI Expectations
Yahoo - 2026-07-07
This Biotech Stock Is Soaring 99% After Vertex Agrees to Takeover Deal
Yahoo - 2026-07-07
Vertex Pharmaceuticals to Buy Crinetics in $10 Billion Deal
Yahoo - 2026-07-07
Vertex signs agreement to acquire Crinetics for $10bn
Yahoo - 2026-07-07
Samsung, Micron, Rivian, SpaceX, Crinetics, and More Stocks That Explain Today’s Market
Yahoo - 2026-07-07
Crinetics (CRNX) Stock Could Be Overvalued After Its 113% Run
SeekingAlpha - 2026-07-07
Andrew Hill Investment Advisors' Q2 2026 Significant Positions
Yahoo - 2026-07-07
Vertex to acquire Crinetics in $10B foray into endocrine disease drugs
SeekingAlpha - 2026-07-07
Vertex To Acquire Crinetics For ~$10bn - What Investors Should Know
Yahoo - 2026-07-07
3 Cash-Heavy Stocks with Promising Prospects
CNBC - 2026-07-07
Stocks making the biggest moves premarket: Fiserv, Crinetics Pharmaceuticals, Micron & more
Benzinga - 2026-07-07
Baird Maintains Underperform on Vertex Pharmaceuticals, Raises Price Target to $350
Benzinga - 2026-07-07
Why Crinetics Pharmaceuticals Shares Are Trading Higher By 99%; Here Are 20 Stocks Moving Premarket
SeekingAlpha - 2026-07-06
Vertex Pharmaceuticals Incorporated (VRTX) M&A Call Transcript
Yahoo - 2026-07-06
CRNX Stock Soars Nearly 100% After-Hours On Vertex's $10B Acquisition
Yahoo - 2026-07-06
Vertex Pharma Makes A $10 Billion Deal; Crinetics Stock Doubles
ChartMill - 2026-07-06
Which S&P500 stocks are showing activity after the closing bell on Monday?
SeekingAlpha - 2026-07-06
Vertex Pharmaceuticals Incorporated (VRTX) Crinetics Pharmaceuticals, Inc. - M&A Call - Slideshow
Yahoo - 2026-07-06
Crinetics soars on $10B acquisition by Vertex
Yahoo - 2026-07-06
Vertex to Acquire Crinetics Pharmaceuticals
Yahoo - 2026-07-06
Vertex Pharmaceuticals Stock Is Soaring and at a New All-Time High. Could It Still Be Heading Even Higher?
Benzinga - 2026-07-06
Crinetics Pharmaceuticals Stock Doubles After The Close: Here's Why
CNBC - 2026-07-06
Vertex to buy Crinetics in an all-cash deal valued at $10 billion
Benzinga - 2026-07-06
Vertex Pharmaceuticals Agrees To Acquire Crinetics Pharmaceuticals For $85/Share In Cash
Yahoo - 2026-07-06
Vertex Signs Letter of Intent (LOI) with the pan-Canadian Pharmaceutical Alliance for ALYFTREK for the Treatment of Cystic Fibrosis
Yahoo - 2026-07-06
CRISPR Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
Yahoo - 2026-07-05
While SpaceX Gets the Headlines, Smart Investors Are Loading Up on This Stock Instead
Yahoo - 2026-07-03
Vertex Pharmaceuticals (VRTX) Wins FDA Approval To Treat Two Year Olds With CASGEVY
Yahoo - 2026-07-03
Wall Street Bulls Look Optimistic About Vertex (VRTX): Should You Buy?
Yahoo - 2026-07-02
CRSP, VRTX Stocks Surge As FDA Clears Casgevy For Children Ages 2 And Up
Yahoo - 2026-07-02
Vertex Gets FDA Nod for Expanded Use of Casgevy in SCD & TDT
Benzinga - 2026-07-02
Vertex Says Casgevy Label Expansion Opens Treatment to 5,500 More Us Children
Benzinga - 2026-07-01
Reported Earlier, Vertex Wins FDA Approval Expanding CASGEVY Use To Children As Young As 2 With Severe Sickle Cell Disease Or Beta Thalassemia
Benzinga - 2026-07-01
FDA Approves First Gene Therapy for Young Children with Sickle Cell Disease; The FDA Granted The Approval To Vertex Pharmaceuticals
Yahoo - 2026-07-01
Dyne Therapeutics vs. Vertex Pharmaceuticals: Which Drug Innovator Stock Is a Better Buy in 2026?
Yahoo - 2026-07-01
Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know
Yahoo - 2026-07-01
BridgeBio gets funding for drug launch; United buys into cell therapy
Yahoo - 2026-06-30
Vortex Energy Corp. Announces LIFE Offering
SeekingAlpha - 2026-06-30
Vertex Pharmaceuticals Has One Of The Widest And Most Durable Moats In Biotech
Benzinga - 2026-06-30
IBM, Verizon, Corning And A Health Care Stock On CNBC’s ‘Final Trades’
Yahoo - 2026-06-29
Nephrotic Syndrome Market Set for Robust Growth During the Forecast Period (2026-2036), Driven by Emerging Therapies and Expanding Research | DelveInsight
CNBC - 2026-06-29
Final Trades: Vertex Pharma, Verizon, IBM and Corning
Benzinga - 2026-06-29
$100 Invested In Vertex Pharmaceuticals 5 Years Ago Would Be Worth This Much Today
Yahoo - 2026-06-27
CRISPR Therapeutics AG vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?
Yahoo - 2026-06-26
Why the Market Dipped But Vertex Pharmaceuticals (VRTX) Gained Today
SeekingAlpha - 2026-06-26
Beam Therapeutics: A Better Entry Point Is Likely Coming (Rating Downgrade)
Yahoo - 2026-06-24
Vertex Energy Announces 6,000 bpd Group III Base Oil Expansion Project
SeekingAlpha - 2026-06-24
Vertex Pharmaceuticals: Povetacicept May Redefine Growth Narrative (Rating Upgrade)
SeekingAlpha - 2026-06-23
Healthcare's Quiet Comeback: Innovation, Obesity Drugs And New Opportunities
Yahoo - 2026-06-23
Vertex Pharmaceuticals (VRTX) Stock After Strong Multi‑Year Run Is The Price Still Reasonable
Yahoo - 2026-06-23
Positive Pediatric CASGEVY Data Might Change The Case For Investing In Vertex Pharmaceuticals (VRTX)
ChartMill - 2026-06-23
Vertex Pharmaceuticals (NASDAQ:VRTX): A GARP Growth Stock with Reasonable Valuation and Strong Fundamentals
SeekingAlpha - 2026-06-23
Moderna: The Comeback Is Now In Full Swing
Yahoo - 2026-06-22
2 Reasons to Like VRTX (and 1 Not So Much)
Yahoo - 2026-06-22
3 of Wall Street’s Favorite Stocks to Consider Right Now
Yahoo - 2026-06-20
Vertex Has a Head Start in Non-Opioid Pain. Eli Lilly Just Spent Billions to Catch Up. Here's What That Means for Both Stocks.
Yahoo - 2026-06-19
Can Vertex's Kidney Pipeline Power Its Next Growth Phase?
Yahoo - 2026-06-18
Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: Here's Why
CNBC - 2026-06-18
Surge in biotech being driven by M&A, says UBS's Michael Yee
Yahoo - 2026-06-18